Stocksigma LogoStocksigma Logo

Emmessar Biotech & Nutrition Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

■ Revenue: 10.9 (+19.1% YoY | +84.1% QoQ) ■ EBITDA: -32.0 (+14.2% YoY | +9.4% QoQ) ■ EBITDA Margin (%): -293 (+11369 bps YoY | +30208 bps QoQ) ■ PAT: 14.0

Emmessar Biotech & Nutrition Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)

Emmessar Biotech & Nutrition Ltd · Outcome · 31 Oct 2026, 9:25 pm

Emmessar Biotech & Nutrition Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 10.9 (+19.1% YoY | +84.1% QoQ) ■ EBITDA: -32.0 (+14.2% YoY | +9.4% QoQ) ■ EBITDA Margin (%): -293 (+11369 bps YoY | +30208 bps QoQ) ■ PAT: 14.0 (+23.1% YoY | +6.7% QoQ) ■ EPS (INR): 0.28 (+21.7% YoY | +7.7% QoQ) Emmessar Biotech & Nutrition Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) Segmental Performance Healthcare ■ Revenue: 10.9 (+19.1% YoY | +84.1% QoQ) ■ EBIT: 7.1 (+5.0% YoY | +72.3% QoQ) ■ EBIT Margin (%): 64.8 (-867 bps YoY | -447 bps QoQ) Rent on leasehold land ■ Revenue: 41.3 (+0.0% YoY | +0.0% QoQ) ■ EBIT: 41.1 (+0.0% YoY | +0.0% QoQ) ■ EBIT Margin (%): 99.4 (+0 bps YoY | +0 bps QoQ) Others ■ Revenue: 10.3 (-18.3% YoY | -18.6% QoQ) ■ EBIT: 10.3 (-18.3% YoY | -18.6% QoQ) ■ EBIT Margin (%): 100 (+0 bps YoY | +0 bps QoQ)

Original exchange filing (PDF)

More announcements from Emmessar Biotech & Nutrition Ltd

All Emmessar Biotech & Nutrition Ltd announcements